Immunotec Inc. (IMM), a direct-to-consumer company and a leader in the nutritional industry (the “Company” or “Immunotec”), today announced its consolidated financial results for the third quarter of Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
“Our Company improved its profitability significantly during the first nine month period of this fiscal year”, said Charles L. Orr, Chief Executive Officer of Immunotec. “During the 3rd quarter, we were pleased to increase our presence in the United States, the largest Direct Selling market in the world”, added Mr. Orr.
DEVELOPMENTS DURING THE THIRD QUARTER
– May 2015 – Immunotec announced that Health Canada granted a new health claim specific to Immunocal’s ability to help increase muscle strength and enhance performance when combined with regular exercise. This achievement is